Banjaras Inc

CLOSEOUT LETTER Banjaras Inc MARCS-CMS 589115 — March 24, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Food & Beverages Recipient: Recipient Name Ms. Sumit Kaur Recipient Title President Banjaras Inc 2707 Gallion Dr. Sugar Land , TX 77479-1979 United States Issuing Office: Division of Southwest Imports United States Dear Ms. Kaur, The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter Ref: CMS 589115 dated September 25, 2019. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Rosa Linda Santos Compliance Officer Content current as of: 02/12/2021 Regulated Product(s) Food & Beverages